 "Eris Lifesciences trades higher for fifth straight trading day")
Eris Lifesciences was up 3% at Rs 817 on the BSE in early morning trade, trading higher for the fifth straight trading day.
The stock of pharmaceutical company outperformed the market by gaining 12% from Rs 732 on February 26, 2018, as compared to 1.3% decline in the S&P BSE Sensex. It is trading close to its highest level at Rs 831, touched on November 30, 2017 in intra-day trade. The stock made debut on bourses on June 26 last year.
The stock of pharmaceutical company outperformed the market by gaining 12% from Rs 732 on February 26, 2018, as compared to 1.3% decline in the S&P BSE Sensex. It is trading close to its highest level at Rs 831, touched on November 30, 2017 in intra-day trade. The stock made debut on bourses on June 26 last year.
Eris Lifesciences, engaged in the business of manufacturing and marketing branded formulations, had raised Rs 7.4 billion through initial public offer by issuing shares at price of Rs 603 per share.
Eris while announcing December quarter results in February said that the Company has completed acquisition of Indian domestic formulation business of Strides Shasun for Rs 5,000 million and 100% shareholding of UTH Healthcare for Rs 128.50 million.
The Company is in the process of making a final determination of fair value for the purpose of purchase price allocation and the same is expected to be completed by March 31, 2018, it added.
According to Business Standard report, after growing organically for almost a decade, Eris made 4 acquisitions of distressed businesses in about a couple of years and is now hoping to turn them around.
Of the four acquisitions, Eris has managed to grow the contributions from Amay and Kindex to its revenues by a whopping 211% this fiscal from FY17. The Ahmedabad-headquartered company is working actively to turn around the other two - Strides (its largest acquisition so far) and niche nutrition player UTH Healthcare, added report. CLICK HERE TO READ FULL REPORT
At 09:46 am; Eris was trading 2% higher at Rs 810 on the BSE, as compared to 0.69% rise in the S&P BSE Sensex. A combined 30,930 shares changed hands on the counter on the BSE and NSE so far.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%